REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 5 filers reported holding REVANCE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,860 | -93.6% | 18,122 | -86.0% | 0.01% | -93.5% |
| Q2 2023 | $3,266,686 | +181.3% | 129,067 | +105.2% | 0.12% | +98.4% |
| Q4 2022 | $1,161,190 | -37.0% | 62,903 | -7.8% | 0.06% | -13.9% |
| Q3 2022 | $1,842,000 | +90.7% | 68,200 | -2.4% | 0.07% | +71.4% |
| Q2 2022 | $966,000 | +109.1% | 69,842 | +280.3% | 0.04% | -54.8% |
| Q3 2020 | $462,000 | – | 18,365 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |